AstraZeneca : AZN

All AstraZeneca Articles

225 Articles

Jon C. Ogg | Jul 16, 2012 at 10:43 AM EDT

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to…

Jon C. Ogg | Jul 10, 2012 at 7:35 AM EDT

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks…

Paul Ausick | Jul 6, 2012 at 4:05 PM EDT

24/7 Wall St. Closing Bell — July 6, 2012: Weak Job Numbers, No Love for Software

The three major US stock indexes opened sharply lower this morning following a tepid report on US job growth. The…

Jon C. Ogg | Jun 30, 2012 at 9:45 AM EDT

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

Some mergers are very straight-forward, and others are just odd. Now we have an answer over whether or not Amylin…

Jon C. Ogg | Jun 5, 2012 at 8:16 AM EDT

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) is back in the rumor mill as far as a buyout, but this time the…

Paul Ausick | May 1, 2012 at 4:03 PM EDT

24/7 Wall St. Closing Bell (WPI, AZN, ANF, SPWR, YGE, COST, MERU, ACI, VECO, PBY, ADM, CPO, AVP, DPZ, PFE, VLO, ABX, JDSU, MRO, FSLR, V, PFCB, DAL, CHK)

The major US stock indexes opened flat this morning but started to move higher following the better-than-expected ISM report on…

Douglas A. McIntyre | May 1, 2012 at 8:32 AM EDT

Stock Upgrades And Downgrades

Canaccord maintains its buy rating on Hologic (NASDAQ: HOLX) after it announced a buyout of Gen-Probe for $3.7. Canaccord also reiterated its buy rating…

Jon C. Ogg | Apr 27, 2012 at 9:15 AM EDT

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is supposed to be acquired by a larger drug company. It is one of the…

Jon C. Ogg | Apr 23, 2012 at 2:54 PM EDT

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

Ardea Biosciences, Inc. (NASDAQ: RDEA) is soaring today on news that AstraZeneca PLC (NYSE: AZN) is paying about $1.26 billion to…

Paul Ausick | Apr 23, 2012 at 7:59 AM EDT

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Diabetes drug maker Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) has hired bankers and lawyers to help the company find a buyer.…

Paul Ausick | Mar 27, 2012 at 9:41 AM EDT

Targacept Gets Mixed Results on Drug Trials (TRGT, AZN)

Development stage drug maker Targacept Inc. (NASDAQ: TRGT) is having its troubles these days. Earlier this month the company said…

Douglas A. McIntyre | Mar 27, 2012 at 6:38 AM EDT

Media Digest (3/27/2012) Reuters, WSJ, NYT, FT, Bloomberg

Increasing numbers of mutual funds have performances tied to huge investments in Apple (NASDAQ: AAPL). (Reuters) Tim Cook, Apple’s CEO,…

Paul Ausick | Mar 26, 2012 at 2:29 PM EDT

Teva Launches Generic Seroquel on First Day of Patent Loss (TEVA, AZN)

We noted earlier today that AstraZeneca plc (NYSE: AZN) had lost a patent ruling and that the company’s anti-pyschotic drug…

Paul Ausick | Mar 26, 2012 at 7:36 AM EDT

AstraZeneca Loses Patent Fight (AZN)

Late last Friday, drug maker AstraZeneca PLC (NYSE: AZN) lost its court fight to prevent a generic version of its…

Paul Ausick | Mar 20, 2012 at 12:44 PM EDT

Targacept Slammed on Failed Drug Trial (TRGT, AZN)

Drug developer Targacept Inc. (NASDAQ: TRGT) and partner AstraZeneca plc (NYSE: AZN) today announced that they will not file for…

1 … 10 11 12 13 14 15

AstraZeneca : AZN

All AstraZeneca Articles

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

24/7 Wall St. Closing Bell — July 6, 2012: Weak Job Numbers, No Love for Software

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

24/7 Wall St. Closing Bell (WPI, AZN, ANF, SPWR, YGE, COST, MERU, ACI, VECO, PBY, ADM, CPO, AVP, DPZ, PFE, VLO, ABX, JDSU, MRO, FSLR, V, PFCB, DAL, CHK)

Stock Upgrades And Downgrades

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Targacept Gets Mixed Results on Drug Trials (TRGT, AZN)

Media Digest (3/27/2012) Reuters, WSJ, NYT, FT, Bloomberg

Teva Launches Generic Seroquel on First Day of Patent Loss (TEVA, AZN)

AstraZeneca Loses Patent Fight (AZN)

Targacept Slammed on Failed Drug Trial (TRGT, AZN)

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Most People Don’t Get to Pick Their Last Day of Work. These 4 ETFs Make Sure the Money Is Ready When It Comes

You Paid Into Social Security for 40 Years. The IRS Can Still Tax 85% of Your Check. These 3 ETFs Even the Score

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Most People Don’t Get to Pick Their Last Day of Work. These 4 ETFs Make Sure the Money Is Ready When It Comes

AstraZeneca : AZN

All AstraZeneca Articles

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

24/7 Wall St. Closing Bell — July 6, 2012: Weak Job Numbers, No Love for Software

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

24/7 Wall St. Closing Bell (WPI, AZN, ANF, SPWR, YGE, COST, MERU, ACI, VECO, PBY, ADM, CPO, AVP, DPZ, PFE, VLO, ABX, JDSU, MRO, FSLR, V, PFCB, DAL, CHK)

Stock Upgrades And Downgrades

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Targacept Gets Mixed Results on Drug Trials (TRGT, AZN)

Media Digest (3/27/2012) Reuters, WSJ, NYT, FT, Bloomberg

Teva Launches Generic Seroquel on First Day of Patent Loss (TEVA, AZN)

AstraZeneca Loses Patent Fight (AZN)

Targacept Slammed on Failed Drug Trial (TRGT, AZN)

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Most People Don’t Get to Pick Their Last Day of Work. These 4 ETFs Make Sure the Money Is Ready When It Comes

You Paid Into Social Security for 40 Years. The IRS Can Still Tax 85% of Your Check. These 3 ETFs Even the Score

Featured Reads

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income